254 related articles for article (PubMed ID: 34116058)
1. Integrated Review of the Assessment of Newborns With Neonatal Abstinence Syndrome.
Casavant SG; Meegan T; Fleming M; Hussain N; Gork S; Cong X
J Obstet Gynecol Neonatal Nurs; 2021 Sep; 50(5):539-548. PubMed ID: 34116058
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review of Newborn Feeding Method and Outcomes Related to Neonatal Abstinence Syndrome.
McQueen K; Taylor C; Murphy-Oikonen J
J Obstet Gynecol Neonatal Nurs; 2019 Jul; 48(4):398-407. PubMed ID: 31034790
[TBL] [Abstract][Full Text] [Related]
3. Breastfeeding promotion for management of neonatal abstinence syndrome.
Pritham UA
J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapies for the treatment of neonatal abstinence syndrome.
Frazier LM; Bobby LE; Gawronski KM
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):987-995. PubMed ID: 32146833
[TBL] [Abstract][Full Text] [Related]
5. The Eat, Sleep, Console Method: A Literature Review.
Nicholson S; Waskosky A
Neonatal Netw; 2022 Nov; 41(6):333-340. PubMed ID: 36446434
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
Binder T; Vavrinková B
Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.
Flannery T; Davis JM; Czynski AJ; Dansereau LM; Oliveira EL; Camardo SA; Lester BM
J Pediatr; 2020 Dec; 227():101-107.e1. PubMed ID: 32805259
[TBL] [Abstract][Full Text] [Related]
8. Reduction in Length of Stay and Morphine Use for NAS With the "Eat, Sleep, Console" Method.
Blount T; Painter A; Freeman E; Grossman M; Sutton AG
Hosp Pediatr; 2019 Aug; 9(8):615-623. PubMed ID: 31285356
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
Ghazanfarpour M; Najafi MN; Roozbeh N; Mashhadi ME; Keramat-Roudi A; Mégarbane B; Tsatsakis A; Moghaddam MMM; Rezaee R
Daru; 2019 Jun; 27(1):423-431. PubMed ID: 31093953
[TBL] [Abstract][Full Text] [Related]
10. Opioid treatment for opioid withdrawal in newborn infants.
Zankl A; Martin J; Davey JG; Osborn DA
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002059. PubMed ID: 34231914
[TBL] [Abstract][Full Text] [Related]
11. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
Jones HE; Fielder A
Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
[TBL] [Abstract][Full Text] [Related]
12. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB; Collett A; Alto WA; O'Brien LM
J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
[TBL] [Abstract][Full Text] [Related]
13. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
14. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
15. Eat, Sleep, Console and Adjunctive Buprenorphine Improved Outcomes in Neonatal Opioid Withdrawal Syndrome.
Hein S; Clouser B; Tamim MM; Lockett D; Brauer K; Cooper L
Adv Neonatal Care; 2021 Feb; 21(1):41-48. PubMed ID: 33278102
[TBL] [Abstract][Full Text] [Related]
16. Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy.
Jones HE; Dengler E; Garrison A; O'Grady KE; Seashore C; Horton E; Andringa K; Jansson LM; Thorp J
Drug Alcohol Depend; 2014 Jan; 134():414-417. PubMed ID: 24290979
[TBL] [Abstract][Full Text] [Related]
17. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
[TBL] [Abstract][Full Text] [Related]
18. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Wachman EM; Schiff DM; Silverstein M
JAMA; 2018 Apr; 319(13):1362-1374. PubMed ID: 29614184
[TBL] [Abstract][Full Text] [Related]
19. Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome.
Mizuno T; McPhail BT; Kamatkar S; Wexelblatt S; Ward L; Christians U; Akinbi HT; Vinks AA
Clin Pharmacokinet; 2021 Feb; 60(2):249-259. PubMed ID: 32939690
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
